High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina

PURPOSE: The purpose of this study was to evaluate the efficacy of HDR brachytherapy for primary or recurrent vaginal cancer. METHODS: Between the years 2000 to 2006, 18 patients with primary or recurrent vaginal cancer were treated with brachytherapy (HDRB). Six patients had primary vaginal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Beriwal, Sushil, Heron, Dwight E, Mogus, Robert, Edwards, Robert P, Kelley, Joseph L, Sukumvanich, Paniti
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270281/
https://www.ncbi.nlm.nih.gov/pubmed/18271958
http://dx.doi.org/10.1186/1748-717X-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270281/
https://www.ncbi.nlm.nih.gov/pubmed/18271958
http://dx.doi.org/10.1186/1748-717X-3-7

Ejemplares similares